Schizophrenia Trial, Recruiting NCT04432116 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT04432116
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 60 years old, male or female
  • People who are covered by a social health insurance scheme
  • People who have read, dated, and signed a consent form agreeing to take part
  • Women who could become pregnant must have a negative pregnancy test and use effective contraception for the whole duration of the study
  • People under legal guardianship may be eligible if their guardian has signed the consent form, and the person themselves has also signed if they are able to do so

For patients with a psychiatric diagnosis (in addition to the above):

  • People who have been formally diagnosed with schizophrenia or a schizophrenia-like psychotic disorder, according to the DSM-5 diagnostic guidelines
  • People who have been formally diagnosed with bipolar disorder, according to the DSM-5 diagnostic guidelines
  • Patients must be taking antipsychotic (neuroleptic) medication — with or without additional anti-parkinsonian or antidepressant medication — to be considered eligible

Who may not be able to join:

  • People diagnosed with a substance use disorder (as defined by DSM-5 guidelines)
  • People who have recently used benzodiazepines (within a timeframe based on how long the drug stays in the body), cannabis (within the two months before joining), or hallucinogenic substances (within a timeframe based on how long the drug stays in the body)
  • People with a neurological condition or lasting effects from a previous neurological problem
  • People diagnosed with Attention Deficit Hyperactivity Disorder (ADHD)
  • People diagnosed with borderline personality disorder
  • People with significant sensory impairment — including vision below a certain level even with glasses or contact lenses — as the study uses visual tasks
  • People currently detained or under a justice protection order
  • Women who are pregnant, recently given birth, or breastfeeding
  • People currently enrolled in another clinical study that has a exclusion period still in effect
  • Patients currently taking benzodiazepines are not eligible

For healthy volunteers only (in addition to the above):

  • People with a history of a major neurological or psychiatric illness who are currently taking psychiatric medication (such as antidepressants, mood stabilisers, antipsychotics, benzodiazepines, or sleeping tablets) are not eligible as a healthy volunteer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33388116471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Registry
ClinicalTrials.gov
Start date
12 August 2021
Est. completion
12 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

EEG index of time expectation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov